CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of circulating tumor DNA for non-invasive cancer analysis. By analyzing genetic mutations in plasma samples, it aims to enhance understanding of tumor evolution and drug resistance, ultimately improving cancer diagnosis and treatment strategies.
Non-invasive genomic analysis of cancer can revolutionize the study of tumour evolution, heterogeneity, and drug resistance.
Clinically applied, this can transform current practice in cancer diagnosis and management.
Cell-free DNA in plasma contains tumour-specific sequences.
This circulating tumour DNA (ctDNA) is a promising source of genomic and diagnostic information, readily accessible non-invasively.
The study of ctDNA is therefore timely and of great importance.
But it is also very challen…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
